Zobrazeno 1 - 10
of 36
pro vyhledávání: '"C A Bizollon"'
Publikováno v:
Clinical Chemistry. 43:2426-2428
Prostate-specific antigen (PSA) is a glycoprotein that is secreted by the prostate into the seminal fluid. Low concentrations of the protein are normally released into blood, but in prostate cancer (CAP) as well as in a high proportion of subjects wi
Publikováno v:
Clinical Chemistry. 39:909-911
Publikováno v:
Clinical chemistry. 43(12)
Autor:
C A, Bizollon, R, Hamdane
Publikováno v:
Therapie. 52(4)
Autor:
A, Maillet, S, Normand, H C, Gunga, A M, Allevard, J M, Cottet-Emard, E, Kihm, F, Strollo, C, Pachiaudi, K A, Kirsch, C A, Bizollon, G, Gauquelin, C, Gharib
Publikováno v:
Advances in space biology and medicine. 5
The EXEMSI experiment has made it clear that it is difficult to perform psychological and physiological protocols satisfactorily in the same study. It is, therefore, essential that the objectives of study be defined clearly before the start. While be
Autor:
A, Maillet, G, Gauquelin, H C, Gunga, J, Collet, J M, Cottet-Emard, A M, Allevard, J O, Fortrat, R, Cartier, B, Claustrat, C A, Bizollon
Publikováno v:
Advances in space biology and medicine. 3
In the ISEMSI confinement experiment we observed three main reactions concerning blood volume regulation: first, a stress activation produced by the high workload that the subjects had to accomplish, both before the isolation period and during the tw
Autor:
Irène Juhan-Vague, C. A. Bizollon, Georges Dureau, Serge Renaud, P. Boissonnat, J. Guidollet, M de Lorgeril
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology
Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association, 1992, 12 (2), pp.222-30
Arteriosclerosis, Thrombosis, and Vascular Biology, 1992, 12 (2), pp.222-30
Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association, 1992, 12 (2), pp.222-30
Arteriosclerosis, Thrombosis, and Vascular Biology, 1992, 12 (2), pp.222-30
International audience; Accelerated coronary artery disease seems to be the main condition limiting long-term survival after heart transplantation. Ninety-one heart transplant recipients were compared with 94 nontransplanted coronary artery disease p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82ba1cb12016e1c9561cbf97786dbf8a
https://hal.archives-ouvertes.fr/hal-00395773
https://hal.archives-ouvertes.fr/hal-00395773
Autor:
M. deLorgeril, Georges Dureau, J. P. Guichard, P. Boissonnat, Serge Renaud, R. Levy-Prades-Sauron, J. Guidollet, C. A. Bizollon, G. Faucon
Publikováno v:
European journal of clinical pharmacology. 43(2)
Cyclosporine (Cy) binds to lipoproteins in plasma. In order to test if its pharmacokinetics would be modified when efficient lipid-lowering treatment is introduced, a study has been done of Cy pharmacokinetics and any interaction with the lipid-lower
Autor:
R, Cohen, C A, Bizollon
Publikováno v:
Annali dell'Istituto superiore di sanita. 27(3)
Several immunoassay external quality assessment schemes (EQAS) are currently operating in France. Three of them are described, special reference being made to their philosophy, aims, structure and organisation. The results obtained since the EQAS wer
Autor:
L, Vernillet, H, Humbert, B, Aupetit, M, Berard, P, Bertault-Peres, E, Billaud, C A, Bizollon, M, Breteau, A M, Brisson, J P, Codet
Publikováno v:
Transplantation proceedings. 22(3)